BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 21925976)

  • 1. Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging.
    O'Brien PJ; Lee M; Spilker ME; Zhang CC; Yan Z; Nichols TC; Li W; Johnson CH; Patti GJ; Siuzdak G
    Cancer Metab; 2013 Jan; 1(1):4. PubMed ID: 24280026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limits of [18F]-FLT PET as a biomarker of proliferation in oncology.
    McKinley ET; Ayers GD; Smith RA; Saleh SA; Zhao P; Washington MK; Coffey RJ; Manning HC
    PLoS One; 2013; 8(3):e58938. PubMed ID: 23554961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography-tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3'-deoxy-3'-fluorothymidine to 3'-deoxy-3'-fluorothymidine monophosphate.
    Faria M; Halquist MS; Kindt E; Li W; Karnes HT; O'Brien PJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():13-20. PubMed ID: 22995377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3'-deoxy-3'-[18F]fluorothymidine flare.
    Lee SJ; Kim SY; Chung JH; Oh SJ; Ryu JS; Hong YS; Kim TW; Moon DH
    Biochem Pharmacol; 2010 Nov; 80(10):1528-36. PubMed ID: 20723540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
    Rasey JS; Grierson JR; Wiens LW; Kolb PD; Schwartz JL
    J Nucl Med; 2002 Sep; 43(9):1210-7. PubMed ID: 12215561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary
    Ko IO; Jung KH; Kim MH; Kang KJ; Lee KC; Kim KM; Noh I; Lee YJ; Lim SM; Kim JY; Park JA
    Contrast Media Mol Imaging; 2017; 2017():3981358. PubMed ID: 29097919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.
    Sala R; Nguyen QD; Patel CB; Mann D; Steinke JH; Vilar R; Aboagye EO
    PLoS One; 2014; 9(7):e101366. PubMed ID: 25003822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring cellular accumulation of 3'-deoxy-3'-fluorothymidine (FLT) and its monophosphate metabolite (FLT-MP) by LC-MS/MS as a measure of cell proliferation in vitro.
    Li W; Araya M; Elliott M; Kang X; Gerk PM; Halquist MS; Karnes HT; Zhang C; O'Brien PJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(28):2963-70. PubMed ID: 21925976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of cell proliferation: status and prospects.
    Bading JR; Shields AF
    J Nucl Med; 2008 Jun; 49 Suppl 2():64S-80S. PubMed ID: 18523066
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.